Valeant Teams With Bill Ackman to Buy Allergan

April 23 (Bloomberg) -- Valeant offered to buy Allergan for about $152.89 a share in a cash-and-stock deal that will give the Canadian company the Botox wrinkle treatment. Stephanie Ruhle reports on Bill Ackman’s involvement on Bloomberg Television’s “In The Loop.” (Source: Bloomberg)

Soylent: The Food of the Future?
13:09 - Rob Rhinehart, Soylent's chief executive officer, discusses the company's quest to disrupt the food industry. He speaks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)
  • Full Show: What'd You Miss? (07/22)
  • Should More Filmmakers Use Virtual Reality Technology?
  • How Important Is the Smartwatch Market to Apple?